Laurus Labs Limited IPO

Laurus Labs Limited is listed in the MAINBOARD segment with a price band of ₹426 to ₹428. The figures below are as reported by the exchanges and public sources.

Laurus Labs Limited IPO — key facts

• The Laurus Labs Limited IPO price band is ₹426 to ₹428 per share.
• As of 5 September 2026, the Laurus Labs Limited IPO subscription status is 4.53x overall.
• The issue is open from 06-DEC-2016 to 08-DEC-2016.
• Laurus Labs Limited listed on 19-DEC-2016.
• Laurus Labs Limited listed at ₹480.4. The listing gain was 12.2% against the upper end of the issue price band.

Laurus Labs Limited IPO details

Status

Listed

Segment

MAINBOARD

Sector

Pharmaceuticals

Price band

₹426 – ₹428

Issue size

₹1330.51 Cr

Fresh issue

₹299.71 Cr

Offer for sale

₹1030.8 Cr

Opens

06-DEC-2016

Closes

08-DEC-2016

Listing

19-DEC-2016

Total subscription

4.53x

Retail

1.58x

QIB

10.54x

NII

3.57x

Lead managers

Citigroup Global (left lead)

Listing price

₹480.4

Listing day change

+12.2%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.